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A B S T R A C T
We report our experience regarding evaluation, surgical treatment and outcomes in a population of 21
children with histopathologically conﬁrmed developmental tumours [nine dysembryoplastic neuroe-
pithelial tumours (DNET), ten gangliogliomas (GG) and two gangliocytomas (GC)] and related epilepsy,
analyzing video-EEG, MRI and neuropsychological data, before and after surgery.
Most children had focal epilepsy correlating well with lesion location. One patient had epileptic
spasms and generalized discharges. Tumours were located in the temporal lobe in 13 patients. Mean age
at surgery was 11.16 years. Postsurgical MRI showed residual tumour growth in one DNET. One child had
a recurrent ganglioglioma with anaplastic transformation. At latest follow-up (mean 4.68 years) 95.2% of
patients were seizure-free and no signiﬁcant neuropsychological declines were observed. Evidence from
our study suggests that, in this setting, surgery should be performed before criteria for refractory
epilepsy are met, particularly in cases with early seizure onset, in order to optimize cognitive outcome.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Around twenty to thirty per cent of long-standing medically
intractable epilepsies are caused by tumours of neuroepithelial
tissue, especially neuronal–glial tumours.1 Gangliogliomas (GGs)
and dysembryoplastic neuroepithelial tumours (DNETs) are the
most common causes and constitute a major pathologic substrate
of children referred for epilepsy surgery. Magnetic resonance
imaging (MRI) reveals characteristic ﬁndings, although rarely
speciﬁc.2 The identiﬁcation of these tumours is of particular
importance, with therapeutic and prognostic implications, due to
their benign behaviour and tendency to mimic more aggressive
tumours, such as oligoastrocytomas.3 DNETs and GGs, together
with gangliocytomas, have been included in Barkovich’s classiﬁ-
cation of malformations of cortical development, as malformations
due to abnormal neoplastic neuronal and glial proliferation with
abnormal cell types, associated with disordered cerebral cortex.4* Corresponding author at: Epilepsy Monitoring Unit (Neurophysiology Section),
Hospital Infantil Universitario Nin˜o Jesu´s, Avenida Mene´ndez Pelayo, 65, 28009
Madrid, Spain. Tel.: +34 91 503 59 00; fax: +34 91 574 46 69.
E-mail address: martagf@hotmail.com (M. Garcı´a-Ferna´ndez).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.06.003Epilepsy is usually the main manifestation of developmental
tumours and, in most cases, the presenting feature. Its electro-
clinical ﬁndings are usually, but not always, concordant with the
location of the lesion. Children with these tumours can be
cognitively normal or present speciﬁc deﬁcits or epilepsy-related
deterioration, including psychopathological manifestations.
Surgery in this setting offers very good results overall, although
some controversy still exists over the best surgical strategies. In
selected cases, intracranial electroencephalogram (EEG) record-
ings and brain mapping may aid in tailoring the resection. Seizure
frequency and oncological morbidity are the most frequently
assessed outcome measures in the literature. However, the
consequences on the neurocognitive and behavioural functioning
domains have been insufﬁciently analyzed to date.
We report our experience regarding the evaluation and surgical
treatment in a paediatric population with developmental tumours
and related epilepsy. Our purpose was to review their pre-surgical
and post-surgical clinical, neurophysiological, neuroimaging and
neuropsychological data and to analyze and speciﬁcally delineate
the ﬁndings with regard to each other. Outcomes were assessed in
terms of a variety of measures, including thorough neuropsycho-
logical testing, in addition to seizure control and oncological
morbidity.vier Ltd. All rights reserved.
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2.1. Study population and data collection
All children (<18 years) with histopathologically conﬁrmed
developmental tumours and epilepsy as the cardinal presenting
neurological manifestation, surgically treated at the Nin˜o Jesu´s
Children’s University Hospital in Madrid, between January 2000
and December 2007, with a postoperative follow-up of at least one
year (N = 21), were selected for this retrospective analysis. Patients
were identiﬁed through our Epilepsy Unit database, which
includes all epilepsy surgery candidates at our centre.
2.2. Description of procedures
All patients had been evaluated under the same pre-surgical
work-up and post-surgical follow-up protocols. Postoperative
seizure outcome was assessed by using Engel’s classiﬁcation.5
Surgical and post-surgical complications were documented.
 Brain MRI: Brain MRI was performed preoperatively and at six
months after surgery. Additionally, in all patients with subtotal
resections, follow-up was continued at twelve months and yearly
thereafter. High-resolution (1.5 or 3.0 T) brain MRI was
performed under a speciﬁc protocol, including a T1-weighted
volumetric study with multiple-plane reconstruction plus
coronal 3 mm slices with T2-weighted and FLAIR sequences.
Depending on the lesion, additional axial slices on T2-weighted
and/or FLAIR images were obtained, as well as additional axial
slices on T2* sequences, for detection of possible calciﬁcations.
Furthermore, a post-gadolinium injection study was performed
with T1-weighted sequences. Tumours were classiﬁed as large
(>2 cm) or small (<2 cm) according to largest diameter
measures on MRI.
 Video-EEG monitoring: Pre- and post-operative video-EEG moni-
toring was performed using a Nicolet machine (BMSI 5000 and
6000 systems), involving scalp electrode placement according to
the international 10–20 system. Additional closely spaced
electrodes were used when indicated. Three patients underwent
additional subdural electrode studies, during a planned two-
stage procedure, in one case during a re-intervention. Follow-up
video-EEG recordings (nap studies) were performed at three, six
and twelve months after surgery and yearly thereafter.
 Neuropsychology: Neuropsychological evaluation entailed the
use of an extensive and comprehensive battery of tests for pre-
and post-operative analysis. A detailed description of the
protocols can be found in a recent publication.6 Postoperative
follow-up was performed twelve months after surgery for every
patient and, in some selected cases (patients with cognitive/
behavioural deﬁcits present after surgery) this period was
extended for up to three to seven years postoperatively. General
cognitive abilities were assessed using the Full Intellectual
Quotient (FIQ) as well as a Verbal and a Performance Intellectual
Quotient (VIQ and PIQ). Speciﬁc cognitive abilities were also
evaluated, involving motor, perceptive visual and auditory
domains, non-verbal abilities, receptive and expressive language,
verbal and non-verbal memory (with immediate memory,
learning and recall measures), attention and executive functions.
Academic abilities (reading, writing and arithmetic) were also
examined. In addition, a psychopathological study was per-
formed. In order to compare the results obtained in the different
tests, mean scores for each group were expressed as Z scores
based on the norms for each test.
 Operative procedure: Gross total tumour resection was performed
whenever possible. Lesionectomies were the operative proce-
dure of choice, as a general criterion. For tumours located on theleft (dominant) lateral temporal region, extended tailored
resections were carried out when epileptogenic foci were found
outside tumour margins, evidenced by subdural electrode
extraoperative video-EEG monitoring, and after language map-
ping using electrical cortical stimulation. Lobectomies were
performed in children with very large tumours with/without
signs of associated focal cortical dysplasia (FCD), involving
extensive areas within the lobe. Re-interventions were planned
when seizures remained uncontrolled after the ﬁrst surgical
procedure and residual tumour was deemed present, or when
residual tumour progression or recurrent tumour was docu-
mented. Intraoperative frameless stereotactic navigation was
used in ﬁve patients to assist with tumour localization.
 Histopathology: Formaline ﬁxed and parafﬁn-embedded tissues
were routinely processed and cut at 3 mm. The sections were
stained by haematoxylin and eosin, in all cases supplemented by
immunohistochemistry with antibodies against glial ﬁbrillary
acidic protein (polyclonal, Dako), Neu N1 (clone A60, Chemicon),
Synaptoﬁsin (clone SY38, Dako), Neuroﬁlaments (clone 2F11,
Dako), Vimentin (clone V9, Dako) and Ki-67 (clone MIB-1, Dako).
A peroxidase/DAB kit (EnVision FLEX, Dako) was used for
visualizing. Histopathological diagnosis was performed follow-
ing latest WHO criteria.
2.3. Statistical analysis
Fisher’s exact test, ANOVA test, dependent t-test for paired
samples, Mann–Whitney’s U test and Spearmann’s correlation
coefﬁcient, were used for statistics. A p value of 0.05 was
considered signiﬁcant. Statistical analysis was performed using
the SPSS (15.0 version) statistical software (SPSS, Inc., Chicago, IL).
3. Results
General results are summarized in Table 1.
3.1. Epilepsy-related and tumour-related pre-surgical clinical data
Our population consists of seven girls and fourteen boys. Mean
age at epilepsy onset was 7.14 years [standard deviation (SD):
4.93]. Seizures began before the age of three years in six patients
(28.57%). Mean duration of epilepsy before surgery was 4.07 years
(SD: 3.37). This duration was of one year or under in six patients
(28.57%). A total of 61.90% of the population (13/21) had medically
intractable epilepsy (deﬁned by failure of two or more medications
to achieve control of seizures), of which three (14.28% of the
population) were under treatment with three or more antiepileptic
drugs at the time of surgery.
Six patients had a family history of epilepsy, only two with ﬁrst-
degree relatives affected, and one patient had a grandfather with a
brain tumour. Two patients had a history of febrile unilateral
convulsive status epilepticus during infancy.
3.2. Pre-surgical MRI ﬁndings and their correlation with pathology
Histopathologically, all patients showed tumours with mixed
neuronal and glioneuronal components: nine DNETs (with
evidence of speciﬁc glioneuronal element in three cases), ten
GGs and two gangliocytomas. Tumours were located to the
temporal lobe in 13 patients.
The main MRI characteristics of histopathologically conﬁrmed
DNETs (Figs. 1 and 2) were: hypointense MRI signals on T1
sequences in 77.78% (7/9) and mixed in 22.22% (2/9); MRI signals
on T2 and FLAIR sequences were hyperintense or mixed in all cases
[88.89% (8/9) and 11.11% (1/9), respectively]; multiple nodular
Table 1
Summarized general data of all patients, including MRI, histopathology, epilepsy/EEG, surgery and outcome.
No. Sex/age at
onset (years)
MRI Pathology Localization Size
(cm)
Epilepsy No. EEG
foci
Gen EEG
discharges
Reg EEG
slow
Drug
resistance
1 F/1.4 DNET + FCD DNET + FCD IIA L frontal >2 FLE 3 No Yes Yes
2 M/13.0 GG GG L basal T >2 TLE 2 No Yes Yes
3 M/0.2 GG GG R medial T >2 TLE 1 No Yes Yes
4 F/0.9 GG GG L medial T >2 TLE 2 Yes No Yes
5 M/1.3 DNET + MTS DNET L post cingulum >2 PsTLE 2 No Yes Yes
6 M/2.6 DNET DNET L parietal >2 PCE 1 Yes Yes No
7 M/15.0 DNET DNET L ant cingulum <2 FLE 1 No No No
8 M/8.5 GG GG L medial T <2 TLE 1 No No Yes
9 M/1.2 GG + FCD GG+ FCD IA R basal T >2 TLE 1 Yes No No
10 M/10.0 GG + FCD GG R lateral T <2 TLE 1 No No No
11 F/12.0 GG GC R occipital <2 PsTLE 2 No No Yes
12 F/8.0 DNET DNET L parietal PR >2 PRE 1 No No No
13 M/16.0 GG + FCD GG R central PR >2 PRE 1 No No No
14 M/7.0 GG GG + FCD IIA* R basal T <2 TLE 1 No No Yes
15 F/6.0 GG + FCD GG L lateral T >2 TLE 2 No Yes Yes
16 M/5.0 GG GG R medial T >2 TLE 3 No Yes Yes
17 F/6.0 DNET DNET L medial T <2 TLE 2 No No Yes
18 M/14.0 DNET DNET L medial T >2 TLE 1 No No No
19 M/12.0 GG GC L lateral T >2 TLE 1 No Yes Yes
20 M/10.0 DNET DNET R ant T >2 TLE 1 No No No
21 F/4.0 DNET DNET L frontal >2 FLE 1 No No Yes
No. No.
AEDs at
surgery
Epilepsy
duration
(years)
Age at
surgery
(years)
Type
surgery
MRI 6 m
postsurgery
Seizure
outcome 6–12 m
post surgery
Reason/type
reoperation
Follow-up
(years)
Seizure
outcome at
latest follow-up
No. AEDs
at latest
follow-up
Pre
FIQ
Post
FIQ
1 2 3.0 4.4 Lob Total resect I / 3.33 I 2 51 88
2 2 3.3 16.3 Les Total resect I Recurrence +
Malign/Les
6.16 I 1 97 100
3 2 1.8 2.0 Lob Total resect I / 7.00 I 0 68 68
4 2 11.0 11.9 Les Total resect I / 7.75 I 1 45 77
5 1 4.3 5.6 Les Total resect I / 7.58 I 1 70 67
6 1 1.0 3.6 Les Residual tum IV Seizures + Residual
tum/Les
4.50 I 1 92 70
7 1 1.0 16.0 Les Total resect I / 1.00 I 0 117 106
8 2 1.0 9.5 Les Total resect I / 1.50 I 2 82 91
9 1 0.9 2.1 Lob Total resect I / 7.00 I 0 96 66
10 1 0.5 10.5 Les Total resect I / 1.91 I 1 94 84
11 2 7.5 19.5 Les Total resect I / 6.08 I 0 90 107
12 2 3.0 11.0 Les Residual tum I Residual tumour
growth/Les
3.66 I 2 85 88
13 1 2.0 18.0 Les Residual tum I / 6.33 I 0 123 123
14 2 7.8 14.8 Les FCD IV Seizures + FCD/Lobs 4.41 I 2 104 106
15 3 10.0 16.0 ExtS Total resect I / 4.66 I 2 51 66
16 2 9.0 14.0 Les Residual tum III Seizures + Residual
tum/Les
4.16 II 3 78 89
17 2 3.0 9.0 Les Total resect I / 3.50 I 1 88 99
18 1 3.0 17.0 Les Total resect I / 2.16 I 1 100 109
19 3 4.0 16.0 ExtS Total resect I / 5.58 I 1 65 70
20 1 0.6 10.6 Les Residual tum I / 7.41 I 0 119 112
21 4 8.0 12.0 Les Total resect I / 2.58 I 3 75 75
M: male, F: female, GG: ganglioglioma, DNET: dysembryoplastic neuroepithelial tumour, GC: gangliocytoma, FCD: focal cortical dysplasia, L: left, R: right, T: temporal, PR:
perirolandic, FLE: frontal lobe epilepsy, TLE: temporal lobe epilepsy, PsTLE: pseudotemporal epilepsy, PCE: posterior cortex epilepsy, PRE: perirolandic epilepsy, AED:
antiepileptic drugs, Lob: lobectomy, Les: lesionectomy, Ext: extended lesionectomy, s: subdural electrodes, *: at re-intervention, FIQ: full intellectual quotient.
M. Garcı´a-Ferna´ndez et al. / Seizure 20 (2011) 616–627618abnormalities of pseudo-cystic appearance were present in 88.88%
(8/9)–this highly characteristic feature was not found in GGs; focal
contrast enhancement was seen in 22.22% (2/9); no oedema nor
calciﬁcations were found. With regard to histopathologically
proven GGs, a wider variety of ﬁndings were seen: MRI signals
on T1 sequences were isointense in 50.0% (5/10), mixed in 40.0% (4/
10) and hypointense in 10.0% (1/10); on T2 and FLAIR sequences,
MRI signals were hyperintense in 70.0% (7/10) and mixed in 30.0%
(3/10); mass effect was found in 20.0% (2/10), gadolinium
enhancement in 80.0% (8/10), calciﬁcations in 20.0% (2/10) and
cerebral oedema in 20.0% (2/10).
Adjacent FCD was conﬁrmed by histopathology in three cases,
all of which were either type IA or IIA, according to Palmini’s
classiﬁcation.7 Such FCD had been previously detected by MRI in
two of them. In one patient, with a DNET located in the posterior
cingulum and history of status epilepticus during infancy,preoperative MRI showed associated mesial temporal sclerosis,
which was not removed.
3.3. Pre-surgical non-invasive video-EEG ﬁndings and epilepsy
classiﬁcation
Seizures were recorded in 16 patients (76.2%), adding up to a
total of 60 seizures available for analysis.
Temporal lobe epilepsy (TLE) was diagnosed in 13 cases (61.9%).
Seizures with typical semiological features were observed in 10 out
of 11 cases with recorded seizures, including some of the
following: abdominal aura, impaired consciousness, psychomotor
arrest, and oral and/or manual automatisms. In most patients, ictal
EEG revealed typical seizure patterns, with a well-deﬁned regional
onset. However, one patient, with epilepsy onset within the ﬁrst
year of life, presented with asymmetric infantile spasms and
Fig. 1. Frontal DNET (patient 1). Left frontal lesion, with a well deﬁned, slightly lobulated border, predominantly hypointense on T1 (A) and hyperintense on T2 (B), but mixed
on FLAIR (C). The lesion consists on multiple small nodules (pseudocysts) with slightly variable signal, mainly on FLAIR sequence, very characteristic of DNETs. There is also a
subtle triangular white matter hyperintensity, pointing to the ventricle, suggesting associated FCD.
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epileptiform discharges were found over the temporal lobe
involved by the tumour. In four patients, two independent EEG
foci were found within the affected temporal lobe, usually
involving a dominant focus at the lateral temporal region and a
secondary focus consisting of sporadic anterior-medial temporal
discharges (<25% of interictal discharges). Another patient had an
independent secondary focus on the contralateral temporal lobe
and sporadic generalized discharges.
Extratemporal epilepsy was diagnosed in eight patients (38.1%),
corresponding to posterior cortex epilepsy in three cases, frontal
lobe epilepsy (FLE) in three, and perirolandic epilepsy in two. Two
patients had ‘‘complex partial seizures’’ with typical features of
temporal lobe origin (‘‘pseudotemporal epilepsy’’) in spite of
having the lesion on the occipital or posterior cingulum cortices.
However, in these cases, interictal and ictal EEG features were less
characteristic and not as well localizable as in true TLE patients.
One of them had a secondary EEG focus over the contralateral
parietal region, suggestive of benign focal epileptiform discharges
of childhood, and the other had a secondary focus over the
ipsilateral posterior temporal region. In one child with a large
parietal lesion, epilepsy began at the age of two and a half years,
with epileptic spasms and generalized EEG discharges, as well as
very persistent regional centro-parietal slow and epileptiform
activity, ipsilateral to the lesion. Patients with FLE had seizures
with impaired consciousness and/or prominent motor manifesta-tions, with well-deﬁned regional epileptic activity on EEG. One girl
with a large left frontal lesion had a dominant left frontopolar
interictal EEG focus and two secondary foci over left central and
midtemporal regions. Both children with perirolandic epilepsy had
sensory-motor manifestations with jacksonian progression and
quite inexpressive interictal EEG abnormalities.
Overall, two or more interictal EEG foci were found in eight
patients (38.1%). Regional polymorphic slow activity, ipsilateral to
the lesion, was found in eight cases (38.1%) and was signiﬁcantly
associated with tumours of large size (p = 0.032).
In most cases, ictal EEG patterns had a regional onset,
concordant with clinical seizure semiology, interictal abnormali-
ties and tumour localization. Four patients showed less localizable
and even generalized ictal EEG patterns, which however did not
unfavourably condition the surgical strategy, due to the congru-
ency of the rest of the data from the pre-surgical evaluation.
3.4. Pre-surgical neuropsychological evaluation
Pre-surgical neuropsychological evaluation was performed in
all patients.
 Tumour location: The cognitive proﬁles of patients with left
hemispheric tumours showed signiﬁcantly lower VIQ (F = 5.87,
p < 0.05) and worse performances in verbal learning (F = 12.18,
p < 0.005), verbal delayed recall (F = 6.102, p < 0.05) and reading
Fig. 2. Temporal DNET (patient 18). Left medial temporal lesion, with a well deﬁned, lobulated border, hypointense on T1 (A), hyperintense on T2 (B) and mixed, but
predominantly hyperintense, on FLAIR (C). Although the multinodular pattern is more difﬁcult to identify than in Fig. 1, it can be observed on the FLAIR sequence. Its
pseudocystic appearance is evident on the diffusion sequence (D) where, in contrast to lesions with liquid content, it only shows a slight hypointensity.
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patients with tumours on the right side. With regard to temporal
or extratemporal location, only the executive function of
resistance to interference showed signiﬁcant differences
(F = 8.682, p < 0.05) with worse performances in the extra-
temporal group. Two adolescents with left lateral temporal
tumours had aphasia, in one case anomic (patient 15) and in the
other transcortical sensory (patient 19).
 Epilepsy onset: Patients with an early age at epilepsy onset (under
six years) had statistically signiﬁcant worse performances in
multiple domains compared to those with a later onset (Fig. 3).
They showed signiﬁcantly lower FIQ (F = 11.903, p < 0.005), VIQ
(F = 7.546, p < 0.05) and PIQ (F = 14.055, p < 0.001) scores as well
as poorer performances in tasks of motor rapidity and precision
with the dominant (F = 11.903, p < 0.05) and non-dominant
hand (F = 8.804, p < 0.05), visomotor coordination (F = 6.396,
p < 0.05), tasks requiring visuo-constructional praxis (F = 10.900,
p < 0.005), verbal reasoning (F = 5.406, p < 0.05), auditory
processing (F = 6.767, p < 0.05), vocabulary recognition
(F = 4.506, p < 0.05), spatial memory (F = 11.208, p < 0.005),
visual learning (F = 6.168, p < 0.05), concept formation
(F = 5.183, p < 0.05) and arithmetic (F = 23.295, p < 0.0001).
 Medical intractability: Similarly to the group with early epilepsy
onset, the drug-resistant group obtained signiﬁcantly poorer
results in terms of general cognitive abilities (FIQ, F = 14.122,
p < 0.001; VIQ, F = 6.023, p < 0.05; PIQ, F = 13.077, p < 0.005),
motor rapidity and precision with the dominant (F = 7.421,p < 0.05) and non-dominant hand (F = 6.114, p < 0.05), visual
perception (visual attention, F = 9.957, p < 0.01; gestalt closure,
F = 4.970, p < 0.05), auditory processing (F = 5.719, p < 0.05),
verbal reasoning (F = 7.794, p < 0.05), vocabulary recognition
(F = 7.912, p < 0.05), verbal comprehension (F = 5.273, p < 0.05),
phonemic and semantic verbal ﬂuency (F = 6.469, p < 0.05 and
F = 15.568, p < 0.001 respectively), verbal learning (F = 14.683,
p < 0.005), delayed verbal recall (F = 5.115, p < 0.05), visual
learning (F = 5.688, p < 0.05), sustained attention (F = 6.355,
p < 0.05) and arithmetic (F = 5.997, p < 0.05) (Fig. 4).
Only two patients had psychopathologic disturbances fulﬁlling
DSM-IV diagnostic criteria. One of these patients, with early-onset
right TLE, presented an attention deﬁcit hyperactivity disorder
(ADHD) of the combined subtype, with an associated impulse
control disorder (patient 9). The other patient, with early-onset
(before two years of age) left FLE, showed an oppositional deﬁant
disorder (patient 1).
3.5. Surgical strategies
Mean age at surgery was 11.16 years (SD 5.60), with four cases
under ﬁve years of age.
 Temporal tumours: Two patients with large right temporal
tumours involving medial structures, one of them with
Fig. 3. Cognitive proﬁles of patients with early and late epilepsy onset. Signiﬁcant differences between both groups are shown with arrows, with better performances in the
late epilepsy onset group.
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amygdalohippocampectomy. Four patients with smaller right
temporal tumours underwent lesionectomies; one of them had a
dominant interictal EEG focus over the right posterior temporal
region and two independent secondary foci over anterior
temporal and parietal regions.Two children with large left lateral temporal tumours (one
of them with suspected associated FCD, as well as two
independent anterior and posterior temporal interictal EEG
foci and associated dysphasia) underwent tailored extended
lesionectomies after subdural electrode video-EEG monitoring
(showing the dominant interictal foci and the ictal onset zone
Fig. 4. Cognitive proﬁles of drug-resistant and non drug-resistant patients. Signiﬁcant differences between both groups are shown with arrows, with better performances in
the non drug-resistant group.
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patients with left temporal tumours underwent lesionec-
tomies. Two of them had a dominant concordant left posterior
temporal EEG focus and an independent secondary left
anterior temporal focus; another patient had a dominant leftanterior temporal focus, independent rare contralateral
anomalies and sporadic generalized discharges during sleep;
the remaining two patients had one left anterior temporal foci,
concordant with lesion location. In all ﬁve cases, resections
were restricted to lesionectomies due to tumour location away
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preserve verbal memory.
 Extratemporal tumours: A frontal subanatomical lobectomy
preserving primary motor cortex was performed in a right-
handed four year-old girl with a large left frontal tumour with
associated FCD. The lesion did not involve the primary motor
cortex as inferred by neuroimaging and intraoperative visuali-
zation of anatomical landmarks. A reliable functional MRI study
could not be performed in this case, considering the patient’s age
and cognitive level, as well as the presence of associated
psychopathological disorders. It was assumed that in the
probable case that expressive language was initially lateralized
to the left hemisphere, the young age of the patient could allow
for its development on the right side after surgery.
The remaining seven patients with extratemporal lesions
underwent lesionectomies.
3.6. Post-surgical follow-up and outcomes
 Seizure outcome: In the ﬁrst year after surgery, class I was
achieved in 85.7% of children, whereas 4.8% were in class III and
the remaining 9.5% showed no worthwhile improvement (class
IV). At latest follow-up (mean 4.68; SD: 2.13), after any re-
interventions had been performed (see below), 95.2% of patients
were class I, and 4.8% (one only patient) were class II.
Antiepileptic medication was discontinued or signiﬁcantly
reduced in 60% of seizure-free patients. All patients who
underwent total resections were seizure-free, compared to
57.1% of those with some residual lesion at 6 months
postoperative MRI. This difference was statistically signiﬁcant
(p = 0.026). None of the several other factors analyzed were
signiﬁcantly associated with seizure outcome (temporal or
extratemporal location, hemisphere, tumour size, type of
tumour, drug-resistance, age at epilepsy onset, epilepsy dura-
tion, age at surgery, type of surgery, number of interictal EEG foci,
generalized interictal EEG discharges).
 Re-interventions: Re-interventions were performed in ﬁve
patients (23.81%), within the period between six months and
two years after surgery. Persistence of seizures was the reason
for reoperation in three children. Two of them had a residual
tumour (a left parietal DNET and a right medial temporal GG)
whereas in the third one, a FCD was suspected on a post-surgical
3 T MRI, not previously detected on the presurgical 1.5 T MRI,
after complete removal of a right temporal GG. The two former
cases underwent lesionectomies, whereas a right temporal
lobectomy was performed in the latter patient, after extra-
operative video-EEG monitoring with subdural electrodes
showed different ictal onsets involving several electrodes on
the subdural grid. A FCD Type IIA was ﬁnally conﬁrmed by
histopathology in this patient. The other two re-operated
patients were a case with a left parietal perirolandic DNET,
due to considerable post-surgical residual tumour growth, and a
case of tumour recurrence with malignant transformation of a
temporal GG, whose cardinal symptoms were related to the
space-occupying lesion (headache, intracranial hypertension)
rather than to the return of uncontrolled seizures. Both cases
underwent lesionectomies. After the re-intervention, the latter
patient underwent intensive oncological treatment, and is
currently asymptomatic after seven years of follow-up.
 Surgical complications or sequelae: None of our patients suffered
from any severe surgical complications. Two patients had
postoperative fever and received antibiotic treatment, one
patient presented transient quadrantanopsia and one case
presented transient loss of visual acuity. Regarding permanent
sequelae, one patient suffered injury to the frontal branch of thefacial nerve. Permanent contralateral superior quadrantanopsia
was documented in both patients who underwent right temporal
lobectomy during re-intervention. Visual ﬁeld deﬁcits were not
documented in the other two patients who underwent right
temporal lobectomy (perimetry testing could not be performed
in one of them due to global cognitive deterioration). Language
and central motor functions were not modiﬁed by surgery in any
patient.
 Neurophysiological follow-up: One year after surgery, EEGs
showed disappearance of interictal epileptiform activity in 13
patients (61.9%). This number increased to 17 patients (81.0%)
at latest follow-up (after re-interventions). Regional spikes
around the tumour excision area were found in four patients
(19.0%) at latest follow-up. Disappearance of ‘‘secondary’’
spike foci or of generalized paroxysmal discharges was
observed in 7/8 (87.5%) and 3/3 (100%) of patients, respec-
tively. Seizure outcome did not signiﬁcantly correlate to the
presence of postsurgical spikes.
 Neuroimaging follow-up: Residual tumour was reported in 6
patients on follow-up MR images obtained six months after
surgery, most of which were of small size (subtotal resections).
Yearly MRI controls were performed in all such patients. Residual
tumour growth was observed in one case with a histopathologi-
cally proven DNET, three years after surgical treatment. Tumour
recurrence and transformation in the form of an anaplastic GG
was observed in a patient with an initial GG, two years after a
macroscopically apparent total resection. Changes with respect
to the preoperative neuroimaging characteristics of the tumour
were observed in both cases of tumour progression, including
contrast enhancement on T2-weighted images or signs of
tumour malignization.
 Neuropsychological outcome: Post-surgical neuropsychological
outcomes were available at one year following surgical
treatment in all patients. The results obtained in the different
cognitive domains of the entire group are shown in Table 2. No
signiﬁcant declines were observed overall. On the contrary,
statistically signiﬁcant improvements were observed pertaining
to perceptive-visual (visual attention, t = 4.000, p < 0.001) and
perceptive-auditory (phonetic discrimination, t = 3.121,
p < 0.05) aspects, non-verbal abilities (line orientation,
t = 2.838, p < 0.05), linguistic performances, both receptive
(grammatical comprehension, t = 3.437, p < 0.005) and expres-
sive (semantic verbal ﬂuency, t = 2.436, p < 0.05), verbal
learning (t = 3.135, p < 0.05) and recall (t = 2.991, p < 0.05),
selective attention (t = 2.590, p < 0.05), as well as some
executive functions (non-verbal ﬂuency, t = 4.591, p < 0.0005).
Changes detected after lesionectomies were compared to those
observed after larger resections (extended lesionectomies and
lobectomies) (Table 2). No signiﬁcant changes (decline or
improvement) occurred after extended resections, whereas
patients with lesionectomies showed signiﬁcant improvement in
visual attention (t = 3.122, p < 0.01), auditory processing
(t = 2.454, p < 0.05), verbal comprehension (t = 2.602,
p < 0.05), verbal delayed recall (t = 2.936, p < 0.05), spatial
memory (t = 3.747, p < 0.005) and some executive functions
such as nonverbal ﬂuency (t = 4.770, p < 0.001).
Comparing postoperative neuropsychological evaluations in
patients with early versus late epilepsy onset, no signiﬁcant
variations are seen in the former group in relation to the
preoperative evaluation, with improvements seen only in gram-
matical comprehension tasks. Post-surgically, results for all
cognitive domains remain lower in this group compared to the
late-onset group, which shows improvements in a higher number
of cognitive habilities (Table 3).
Table 2
Patients’ Z score means and standard deviations before and one year after surgery. Global results are shown as well as results in the group of patients with lesionectomies and
in the group of patients with larger resections (extended lesionectomies and lobectomies).
Total (N = 21) Lesionectomy (N = 16) Extended (N = 5)
Presurgery Postsurgery Sig. Presurgery Postsurgery Sig. Presurgery Postsurgery Sig.
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Verbal IQ 0.96 (1.5) 0.71 (1.10) 0.64 (1.38) 0.41 (1.14) 1.57 (1.68) 1.27 (0.81)
Performance IQ 0.82 (1.4) 0.46 (1.41) 0.41 (1.45) 0.03 (1.35) 1.58 (1.18) 1.35 (1.11)
Full scale IQ 0.98 (1.5) 0.76 (1.21) 0.55 (1.43) 0.42 (1.20) 1.79 (1.39) 1.40 (1.03)
Manual speed/preferred hand 0.46 (1.0) 0.26 (0.73) 0.33 (1.07) 0.06 (0.65) 0.79 (0.64) 0.69 (0.77)
Manual speed/nonpreferred hand 0.60 (1.0) 0.38 (0.83) 0.49 (1.05) 0.19 (0.80) 0.95 (0.68) 0.88 (0.77)
Visomotor coordination 0.52 (1.7) 0.18 (1.23) 0.64 (2.01) 0.09 (0.97) 0.28 (1.08) 0.70 (1.56)
Visual attention 0.12 (1.3) 0.47 (1.28) ** 0.19 (1.41) 0.72 (1.36) ** 0.86 (0.69) 0.07 (0.97)
Gestalt closure 0.39 (1.0) 0.10 (0.85) 0.14 (1.05) 0.17 (0.88) 0.86 (0.84) 0.04 (0.85)
Line orientation 0.28 (1.6) 0.87 (1.16) * 0.18 (1.86) 0.74 (1.30) 0.59 (0.67) 1.27 (0.46)
Face recognition 0.02 (0.8) 0.23 (0.64) 0.06 (0.56) 0.23 (0.71) 0.28 (1.47) 0.23 (0.45)
Visuo-constructional praxis 0.41 (1.3) 0.22 (1.7) 0.51 (1.45) 0.24 (1.82) 0.20 (1.01) 0.17 (1.56)
Nonverbal reasoning 0.70 (1.0) 0.63 (1.26) 0.38 (0.90) 0.15 (1.12 1.48 (1.02) 1.68 (0.88)
Verbal reasoning 0.71 (1.4) 0.53 (1.28) 0.30 (1.18) 0.17 (1.20) 1.61 (1.46) 1.21 (1.22)
Auditory processing 0.65 (1.7) 0.18 (1.65) * 0.10 (1.68) 0.47 (1.58) * 1.74 (1.35) 1.22 (1.20)
Recognition vocabulary 0.46 (1.6) 0.21 (1.4) 0.09 (1.31) 0.17 (1.34) 1.48 (1.58) 0.93 (1.30)
Verbal comprehension 0.07 (1.7) 0.31 (1.71) ** 0.49 (1.18) 0.90 (0.98) * 1.18 (2.01) 0.79 (2.28)
Naming 0.66 (1.7) 0.43 (1.69) 0.01 (1.09) 0.29 (0.92) 1.91 (2.11) 1.77 (2.03)
Word ﬂuency/phonetic association 0.23 (1.3) 0.04 (1.37) 0.19 (1.27) 0.46 (1.18) 1.25 (0.89) 0.81 (1.44)
Word ﬂuency/semantic association 0.59 (1.0) 0.05 (1.17) * 0.31 (0.98) 0.33 (1.17) 1.18 (0.86) 0.45 (1.06)
Memory for sentences 0.88 (1.5) 0.46 (1.22) 0.44 (1.05) 0.08 (0.89) 1.68 (2.02) 1.16 (1.50)
Verbal learning 0.77 (1.4) 0.38 (1.06) * 0.55 (1.34) 0.30 (0.83) 1.43 (1.66) 0.64 (1.75)
Verbal delayed recall 0.67 (1.4) 0.24 (0.98) * 0.60 (1.49) 0.41 (0.79) ** 0.88 (1.49) 0.32 (1.42)
Spatial memory 0.26 (1.4) 0.26 (1.26) 0.56 (1.51) 0.77 (1.46) ** 0.29 (1.20) 0.67 (1.70)
Visual learning 0.12 (1.3) 0.19 (1.03) 0.11 (1.46) 0.18 (1.04) 0.17 (0.79) 0.25 (1.16)
Visual delayed recall 0.26 (0.8) 0.09 (0.45) 0.25 (0.85) 0.20 (0.29) 0.29 (0.48) 0.25 (0.74)
Sustained attention/speed of processing 0.79 (1.0) 0.98 (1.17) 0.53 (0.93) 0.57 (0.80) 1.33 (1.08) 1.75 (1.41)
Divided attention 1.04 (0.8) 1.04 (0.54) 0.87 (0.82) 0.98 (0.54) 1.54 (0.38) 1.22 (0.60)
Selective attention 1.22 (1.1) 0.43 (1.39) * 1.12 (1.27) 0.22 (1.35) 1.51 (0.36) 1.08 (1.51)
Executive functions/motor sequencing 0.18 (0.9) 0.10 (1.08) 0.00 (0.66) 0.46 (0.75) 0.52 (1.30) 0.57 (1.33)
Executive functions/concept formation 0.53 (1.2) 0.26 (1.42) 0.06 (0.88) 0.26 (1.18) 1.46 (1.15) 1.23 (1.39)
Executive functions/interference 0.29 (0.7) 0.35 (0.46) 0.34 (0.82) 0.39 (0.50) 0.13 (0.44) 0.24 (0.32)
Executive functions/nonverbal ﬂuency 1.07 (1.5) 0.08 (1.61) *** 0.97 (1.35) 0.23 (1.51) *** 1.39 (2.15) 0.36 (2.06)
Executive functions/operative memory 0.85 (0.9) 0.66 (1.21) 0.47 (0.44) 0.30 (1.06) 1.68 (1.02) 1.33 (1.24)
Reading/decoding 0.12 (1.2) 0.22 (1.22) 0.03 (1.25) 0.01 (1.24) 0.49 (1.17) 0.96 (0.91)
Reading/understanding 0.12 (1.1) 0.16 (1.06) 0.03 (0.94) 0.41 (1.14) 0.58 (1.52) 1.17 (0.55)
Writing/dictation 0.28 (1.0) 0.27 (1.9) 0.12 (0.94) 0.03 (1.35) 0.77 (1.08) 1.04 (1.41)
Arithmetic 0.82 (1.2) 0.82 (1.25) 0.46 (1.05) 0.42 (1.20) 1.60 (1.07) 0.96 (0.91)
Statistically signiﬁcant postsurgical improvements are highlighted in bold.
* p < 0.05.
** p < 0.005.
*** p < 0.0005.
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neuropsychological evaluations, patients with non drug-resistant
epilepsy maintain better cognitive proﬁles than those with
intractable epilepsy, but show few variations when comparing
with pre-surgical performances. Patients in the drug-resistant
group exhibit improvements in many more cognitive domains
than the other group. These latter results may partly be explained
by a better seizure control and the reduction of medication at one
year after surgery, nevertheless, their cognitive proﬁles remain
poorer than those in patients with non drug-resistant epilepsy
(Table 4).
All pre-surgical associated conditions, both dyscognitive and
psychopathological, persist after surgery, with the exception of the
patient with a left FLE, who no longer presented a disorder of
conduct. In spite of good seizure control, one patient with a right
temporal lobe tumour, who had ADHD and was surgically treated
before three years of age, suffered a global deterioration, involving
all functioning domains. Neuropsychological post-surgical follow-
up was extended to seven years in this case and persistence of the
deterioration and associated psychopathologic disturbances was
then conﬁrmed. A patient with a left parietal tumour, who was re-
operated due to persistence of seizures and residual tumour,
showed an FIQ decline of 22 points that remained stable after six
years of follow-up.4. Discussion
GGs and DNETs are the most frequent neoplasms associated
with epilepsy. The temporal lobe is the most frequent site for both
GGs and DNETs.8–10 In tune with these results from other large
published series, overall tumour location in our study involved
more frequently temporal than extratemporal regions (ratio
1.6:1.0). This was also true for location of GGs, whereas
extratemporal location was the most frequent site for DNETs in
our series, with only one third harboured in the temporal lobe.
Congruency between lesion location and electro-clinical setting
was good for the great majority of our patients. The few exceptions
merit further discussion. Epileptic spasms was the initial seizure
type in one patient whose epilepsy onset was before three years of
age, who had an epileptic encephalopathy with frequent and
widely distributed EEG discharges. Besides, two patients with
lesions situated in the posterior quadrant had ‘‘pseudotemporal’’
lobe epilepsy, an idea which has been proposed, in which temporal
lobe EEG discharges and temporal-like seizures may be induced by
an epileptogenic lesion elsewhere. In our series, these two patients
were rendered seizure-free after lesionectomy, sparing the
temporal lobe. Moreover, although overall congruency is quite
good in our patients, occasional secondary EEG foci were found
nearby the lesion. Similar situations have been stressed in some
Table 3
Patients’ Z score means and standard deviations before and one year after surgery in the group of patients with early epilepsy onset and in those with late epilepsy onset.
Signiﬁcant values of paired samples t-test in each group are highlighted in bold.
Cognitive measure Early onset (N = 8) Late onset (N = 13)
Pre-surgery Post-surgery Sig. Pre-surgery Post-surgery Sig.
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Verbal IQ 1.77 (1.39) 1.41 (1.41) 0.16 (1.22) 0.02 (0.96)
Performance IQ 1.76 (1.22) 1.21 (1.37) 0.11 (1.00) 0.29 (1.04)
Full scale IQ 1.91 (1.21) 1.57 (0.78) 0.06 (1.19) 0.05 (1.02)
Manual speed/preferred hand 1.09 (0.95) 0.57 (0.42) 0.03 (0.74) 0.02 (0.85)
Manual speed/nonpreferred hand 1.36 (1.06) 0.99 (0.86) 0.16 (0.58) 0.10 (0.40)
Visomotor coordination 1.52 (2.09) 0.93 (1.30) 0.28 (0.80) 0.56 (0.53)
Visual attention 0.81 (1.20) 0.34 (0.94) 0.37 (1.22) 1.20 (1.11) **
Gestalt closure 0.78 (1.19) 0.07 (1.03) 0.01 (0.66) 0.27 (0.64)
Line orientation 0.46 (2.51) 0.48 (1.79) 0.73 (0.59) 1.11 (0.53)
Face recognition 0.32 (1.17) 0.58 (0.70) 0.15 (0.55) 0.02 (0.52)
Visuo-constructional praxis 1.35 (1.37) 0.92 (1.79) 0.32 (0.61) 0.42 (1.40)
Nonverbal reasoning 0.99 (1.16) 1.13 (1.39) 0.50 (0.96) 0.18 (0.99)
Verbal reasoning 1.41 (1.36) 0.80 (1.23) 0.09 (1.13) 0.27 (1.34)
Auditory processing 1.68 (1.20) 1.11 (1.12) 0.17 (1.69) 0.88 (1.52)
Recognition vocabulary 1.14 (1.48) 0.90 (1.08) 0.23 (1.40) 0.48 (1.38)
Verbal comprehension 0.89 (1.75) 0.45 (1.97) * 0.59 (1.30) 1.07 (1.00)
Naming 1.15 (1.48) 0.66 (1.14) 0.17 (1.92) 0.20 (2.14)
Word ﬂuency/phonetic association 0.87 (0.69) 0.64 (1.06) 0.21 (1.51) 0.59 (1.39)
Word ﬂuency/semantic association 1.05 (0.73) 0.43 (1.26) 0.24 (1.08) 0.54 (0.88) *
Memory for sentences 1.25 (1.88) 0.65 (1.36) 0.51 (1.07) 0.27 (1.10)
Verbal learning 1.33 (0.83) 0.04 (1.17) 0.43 (1.63) 0.67 (0.92) *
Verbal delayed recall 0.70 (0.97) 0.44 (1.05) 0.66 (1.72) 0.72 (0.59) **
Spatial memory 0.60 (1.13) 0.73 (1.61) 1.13 (1.19) 1.26 (0.99)
Visual learning 0.78 (0.89) 0.38 (0.78) 0.67 (1.24) 0.60 (1.03)
Visual delayed recall 0.72 (1.02) 0.05 (0.65) 0.02 (0.40) 0.20 (0.23)
Sustained attention/speed of processing 1.45 (0.58) 1.46 (1.27) 0.27 (1.02) 0.51 (0.88)
Divided attention 1.43 (1.03) 0.98 (0.52) 0.80 (0.51) 1.07 (0.58)
Selective attention 1.84 (1.18) 1.36 (0.88) 0.81 (0.88) 0.29 (1.31)
Executive functions/motor sequencing 0.53 (1.01) 0.20 (1.40) 0.17 (0.75) 0.40 (0.54)
Executive functions/concept formation 1.16 (0.88) 0.76 (1.60) 0.03 (1.16) 0.23 (1.09)
Executive functions/interference 0.41 (0.92) 0.31 (0.29) 0.22 (0.64) 0.38 (0.55)
Executive functions/nonverbal ﬂuency 1.79 (1.86) 0.90 (1.36) 0.64 (1.17) 0.68 (1.51) **
Executive functions/operative memory 1.00 (1.09) 1.15 (1.07) 0.72 (0.63) 0.17 (1.18)
Reading/decoding 0.01 (1.19) 0.45 (1.07) 0.20 (1.30) 0.03 (1.36)
Reading/understanding 0.32 (1.29) 0.40 (1.11) 0.00 (1.00) 0.02 (1.05)
Writing/dictation 0.35 (1.13) 0.50 (1.27) 0.23 (0.94) 0.13 (1.02)
Arithmetic 1.72 (0.81) 1.55 (1.13) 0.00 (0.74) 0.09 (0.92)
* p < 0.05.
** p < 0.005.
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of our patients after surgery, including any secondary foci. Overall,
the prognosis does not seem to be affected adversely by any of the
discordant EEG ﬁndings that were analyzed.
In 38.1% of our patients, surgical interventions were performed
before medical intractability could be demonstrated. Our criteria
for performing a relatively early operation is based on the attempt
to minimize oncological risks, considering that only histopatho-
logical diagnosis offers the highest level of security for typifying
these tumours. Various authors recommend relatively early
surgery in this type of lesions.10,12 An additional argument is
related to improved neuropsychological outcome, allowing for
normal cognitive development as soon as possible and avoidance
of the adverse behavioural and psychosocial consequences of
epilepsy. In fact, in our series, a signiﬁcantly worse neuropsycho-
logical outcome was documented in the group of patients who
were drug-resistant at surgery compared to those with previously
well-controlled epilepsy.
Children with low-grade tumours may sometimes associate
lesions that condition the pre-surgical work-up and management.
In our series, associated mesial temporal sclerosis was identiﬁed in
one child with history of status epilepticus during infancy.
Approximately 30% of DNETs associate subtle MRI-visible dysplas-
tic changes.10 The association of DNET and FCD is revealed much
stronger when taking into account histopathological studies. Infact, two studies have reported percentages as high as 69% and
83.3%.9,22 Histopathology revealed associated FCD in only three of
our patients (14.3%), all with lobectomies. Bearing in mind that
many patients underwent only lesionectomy resections, one
should expect that any associated FCD might have escaped
histopathological detection. This is a likely explanation for the
smaller proportion of associated FCD encountered in our study.
A new ILAE classiﬁcation proposal of FCD has been recently
published.23 According to this system, the two patients in our
series with associated FCD Type IIA would be classiﬁed as ‘‘Double’’
pathology, since both lesions have most likely an independent
pathogenesis. The other case from our series, with a right temporal
GG and associated FCD Type IA, would correspond to the novel ILAE
FCD Type III subgroup. Among patients in which FCD could be
conﬁrmed in our series, it is most interesting to ﬁnd such a high
proportion of Type IIA (2/3) and that at least one of them did not
achieve seizure control in spite of gross total tumour resection,
requiring re-intervention. The resection of associated FCD Type IIA,
with a probably independent underlying pathogenesis, may
inﬂuence seizure outcome to a greater extent compared to that
of Type I.
Our results with regard to seizure outcome are similar to other
surgical series, with independence of the surgical procedure. Some
authors refer good results after lesionectomy, whereas others
advocate for an extended resection guided by electrocorticogra-
Table 4
Patients’ Z score means and standard deviations before and one year after surgery in the group of patients with drug-resistant epilepsy and in those with non drug-resistant
epilepsy. Signiﬁcant values of paired samples t-test are highlighted in bold.
Cognitive measure Drug-resistant (N = 13) Non drug-resistant (N = 8)
Pre-surgery Post-surgery Sig. Pre-surgery Post-surgery Sig.
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Verbal IQ 1.45 (1.38) 1.06 (0.92) 0.17 (1.27) 0.09 (1.14)
Performance IQ 1.42 (1.23) 1.00 (1.20) 0.58 (0.82) 0.82 (1.01)
Full scale IQ 1.62 (1.24) 1.11 (1.03) 0.50 (0.91) 0.05 (1.31)
Manual speed/preferred hand 0.81 (0.93) 0.51 (0.73) 0.37 (0.38) 0.28 (0.35)
Manual speed/nonpreferred hand 0.96 (0.97) 0.67 (0.88) 0.18 (0.16) 0.19 (0.26)
Visomotor coordination 0.93 (1.87) 0.48 (1.29) 0.57 (0.36) 0.51 (0.75)
Visual attention 0.64 (1.02) 0.12 (0.82) ** 1.13 (1.15) 1.22 (1.81)
Gestalt closure 0.69 (1.01) 0.06 (0.89) * 0.31 (0.65) 0.19 (0.82)
Line orientation 0.03 (1.90) 0.78 (1.35) * 0.97 (0.39) 1.08 (0.60)
Face recognition 0.10 (0.99) 0.38 (0.61) 0.14 (0.31) 0.11 (0.63)
Visuo-constructional praxis 0.63 (1.43) 0.39 (1.69) 0.25 (0.42) 0.16 (1.81)
Nonverbal reasoning 0.94 (1.06) 0.79 (1.41) 0.12(0.81) 0.28 (1.14)
Verbal reasoning 1.23 (1.20) 0.80 (1.30) 0.40 (1.12) 0.10 (1.08)
Auditory processing 1.18 (1.34) 0.63 (1.45) * 0.74 (2.00) 1.09 (1.56)
Recognition vocabulary 1.01 (1.47) 0.69 (1.29) 0.83 (0.94) 0.89 (1.02)
Verbal comprehension 0.56 (1.65) 0.08 (1.86) ** 1.22 (0.74) 1.21 (0.83)
Naming 1.13 (1.73) 0.93 (1.66) 0.42 (1.33) 0.73 (1.17)
Word ﬂuency/phonetic association 0.69 (1.08) 0.14 (1.43) ** 0.86 (1.30) 0.52 (1.21)
Word ﬂuency/semantic association 1.02 (0.76) 0.08 (1.16) * 0.51 (0.69) 0.36 (1.25)
Memory for sentences 1.21 (1.63) 0.75 (1.19) 0.11(1.03) 0.21 (1.10)
Verbal learning 1.43 (1.11) 0.27 (1.12) ** 0.69 (0.78) 0.59 (1.00)
Verbal delayed recall 1.16 (1.28) 0.01 (1.00) * 0.40 (1.27) 0.67 (0.84)
Spatial memory 0.04 (1.47) 0.02 (1.73) 0.78 (1.32) 0.83 (1.44)
Visual learning 0.33 (1.13) 0.03 (0.90) 1.13 (1.15) 0.61 (1.22)
Visual delayed recall 0.50 (0.78) 0.06 (0.53) 0.26 (0.36) 0.17 (0.28)
Sustained attention/speed of processing 1.12 (1.00) 1.04 (1.38) 0.07 (0.47) 0.85 (0.46)
Divided attention 1.26 (0.79) 0.88 (0.54) 0.56 (0.54) 1.38 (0.43)
Selective attention 1.40 (1.09) 0.40 (1.54) * 0.75 (1.14) 0.49 (1.16)
Executive functions/motor sequencing 0.31 (1.01) 0.05 (1.25) 0.11 (0.72) 0.22 (0.58)
Executive functions/concept formation 0.82 (1.25) 0.58 (1.55) 0.23 (0.33) 0.46 (0.75)
Executive functions/interference 0.35 (0.86) 0.23 (0.40) 0.15 (0.42) 0.63 (0.49)
Executive functions/nonverbal ﬂuency 1.39 (1.48) 0.38 (1.56) ** 0.36 (1.49) 1.10 (1.33) *
Executive functions/operative memory 0.98 (0.99) 0.90 (1.16) 0.59 (0.44) 0.10 (1.23)
Reading/decoding 0.31 (1.24) 0.43 (1.29) 0.32 (1.17) 0.21 (1.02)
Reading/understanding 0.44 (1.08) 0.58 (0.93) 0.57 (0.80) 0.76 (0.70)
Writing/dictation 0.59 (0.94) 0.63 (1.00) 0.41 (0.73) 0.53 (0.91)
Arithmetic 1.21 (1.08) 1.06 (1.36) 0.03 (0.89) 0.26 (0.79)
* p < 0.05.
** p < 0.005.
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cortical dysplasia and the potential existence of different seizure
onset zones and independent irritative zones.13–15 In tune with
what has been previously reported in the literature, we have not
found a signiﬁcant relationship between type of surgical procedure
and seizure outcome. The only factor signiﬁcantly related to
seizure control in our series was gross total tumour resection.
After epilepsy surgery, most protocols include an MRI follow-up
study within the following year. In patients with developmental
tumours, additional yearly controls are recommended thereafter,
particularly in patients with subtotal resections and evidence of
residual tumour in the ﬁrst postoperative MRI, who have been
identiﬁed to have a statistically signiﬁcant higher risk of tumour
growth or malignization.8 In our series, one child with a DNET
experienced post-surgical tumour growth over small residual
tumour portions. Tumour recurrence was evidenced one year after
surgery in another patient, with anaplastic transformation of a GG.
In a surgical series of 184 GGs, ﬁve tumour recurrences and three
malignant tumour progressions into glioblastomas were identiﬁed
after a mean follow-up of eight years.8 In another series of 34 GGs,
tumour progression was evidenced in three patients, of which two
experienced malignant transformation into a glioblastoma.16 In
most reported series involving GG resections, including ours,
recurrences occur between one and three years after surgery.
However, two series have identiﬁed recurrences and malignanttransformations as late as between ﬁve and eleven years post-
surgically.17,18 Very few cases of DNETs that undergo malignant
transformation have been reported.19–21
In spite of the fact that the importance of a comprehensive
neuropsychological evaluation in these paediatric populations has
been increasingly recognized in the last few years, many of the
studies on the topic still fail to include detailed information
regarding these aspects in their reports.24 Our study conﬁrms that
although overall neuropsychological prognosis is good in these
patients, early epilepsy onset and drug-resistance are signiﬁcantly
associated with a worse outcome. One year after surgery, no
signiﬁcant declines were observed overall. On the contrary,
statistically signiﬁcant improvements were observed pertaining
to certain speciﬁc neuropsychological domains. This is probably
related to the improved control of epilepsy and the reduction of
antiepileptic drug treatment. Only two of our patients (9.5% of the
total population) experienced a signiﬁcant FIQ decline, one of them
with a poor seizure control after surgery, which required
reintervention. However, the other patient, with a right temporal
lobe tumour and ADHD, operated before the age of three years,
experienced a global decline after surgery in spite of a good seizure
outcome. During infancy, in right-handed subjects, functional
brain activity is greater in the right hemisphere than in the left, and
shifts from right-to-left predominance during the fourth year of
life.25 This right hemispheric dominance during the ﬁrst three
M. Garcı´a-Ferna´ndez et al. / Seizure 20 (2011) 616–627 627years of life may be an important risk factor that must be seriously
taken into account when planning surgical management. When
comparing lesionectomy patients to those with extended resec-
tions in our series, signiﬁcant improvements with regard to some
speciﬁc neuropsychological domains were found in the former but
not in the latter. This could also be related to other factors, such as a
higher prevalence of previous drug-resistance in the group with
extended resections.
5. Conclusions
In the quest for attaining favourable seizure and oncological
outcomes while achieving maximum cognitive potential, paediat-
ric patients with developmental tumours and epilepsy must be
promptly and thoroughly evaluated for early surgery, under a
relatively individualized ‘‘epilepsy surgery’’ approach. Serial post-
surgical MRI follow-up is strongly recommended, especially in
patients with evidence of residual tumour. In our series, gross total
resection of the tumour was the only factor signiﬁcantly associated
with a positive seizure outcome. Overall, surgery does not cause
additional neuropsychological deﬁcits, but cognitive disturbances
may persist in spite of a good postoperative seizure control.
Evidence from our study leads us to believe that, in this setting,
surgery should be performed before criteria for refractory epilepsy
are met, particularly in cases with early seizure onset, in order to
optimize cognitive outcome, although these results need to be
reproduced in larger series. This in turn brings up the interesting
idea that the same approach could be extrapolated to other cases of
surgically remediable epilepsies and potentially drug-resistant
lesions, such as medial temporal sclerosis or focal cortical
dysplasia.
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